Sensius

Sensius is a biotechnology startup, with headquarters in The Netherlands, founded in 2015. The company's mission is to establish thermotherapy as a key treatment alongside traditional modalities for cancer patients. Sensius aims to deliver optimized radiotherapy treatment outcomes for patients with head and neck cancer, focusing on balancing efficacy with quality of life. Their recent achievement includes a significant milestone in funding, with a €1.70M grant investment from The European Innovation Council on 15 February 2023. With its focus on improving cancer treatment and the backing of notable European investors, Sensius is poised to make a meaningful impact in the field of healthcare.